Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Venkat Nelabhotla
|
| gptkbp:clinicalTrialPhase |
Phase 2 clinical trials for acne treatment
|
| gptkbp:developedBy |
novel drugs for skin diseases
|
| gptkbp:focusesOn |
dermatology
antibiotic resistance |
| gptkbp:foundedIn |
2010
|
| gptkbp:founder |
gptkb:Raghunath_Mashelkar
Jacob Raj Rajesh Gokhale Shiladitya Sengupta |
| gptkbp:headquartersLocation |
gptkb:India
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vyome Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
VB-001
VB-1953 |
| gptkbp:researchArea |
gptkb:antibiotic
fungal infections acne |
| gptkbp:specializesIn |
topical therapeutics
|
| gptkbp:website |
https://www.vyome.in/
|
| gptkbp:bfsParent |
gptkb:Sumit_Agarwal
|
| gptkbp:bfsLayer |
7
|